Influence of platelet hemostasis on QT interval dispersion in patients with chronic ischemic heart disease and COVID-19
V.Z. Netiazhenko1, 3, S.E. Mostovyi1, 2, K.O. Mikhaliev3
- Bogomolets National Medical University, Kyiv, Ukraine
- SE «Medbud», Kyiv, Ukraine
- State Institution of Science «Center of Innovative Healthcare Technologies» State Administrative Department, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz70.06.031
Abstract
Coronavirus disease COVID-19 impairs platelet hemostasis, heart rate variability (HRV) and QT interval
dispersion, increasing the risk of thromboembolic complications and cardiovascular mortality. Our study
aimed to investigate the impact of COVID-19 on the interdependence of changes in platelet hemostasis
and QT interval dispersion in patients with ischemic heart disease (IHD). We analyzed laboratory and
instrumental results of 102 patients divided into 3 groups: group 1 consisted of IHD without COVID-19
patients (n = 32); group 2 − IHD in combination with COVID-19 (n = 35); group 3 − COVID-19 without
IHD (n = 35). The control group included 30 conditionally healthy volunteers. Changes in platelet hemostasis
were studied with laser aggregometry using the Born turbidimetric method and with light transmission
fluctuation analysis using an assessment of spontaneous and induced aggregation: adenosine diphosphate
(ADP), arachidonic acid, epinephrine, collagen, and ristomycin. The results of 24-hour Holter ECG
monitoring were used to determine the QT interval dispersion. In patients of group 2, there was an increase
in the degree, rate and time of spontaneous platelet aggregation, as well as a decrease in the degree, rate
and time of platelet aggregation induced by epinephrine, a decrease in the rate of aggregation induced by
arachidonic acid and ADP. The degree of aggregation was higher when using collagen and ristomycin. The
QT interval duration and variability increased in all patients, especially in group 2. The time of spontaneous
aggregation, as well as ADP- and collagen-induced aggregation, was directly correlated with the QT mode
and mean. The standard deviation and coefficient of variation of QT were inversely related to the time of
spontaneous aggregation, collagen- and ristomycin-induced and arachidonic acid-induced aggregation.
The rate of aggregation did not affect the QT interval variability. Thus, patients with IHD and concomitant
COVID-19 along with platelet hemostasis dysfunction exhibited signs of autonomic dysregulation and
increased QT interval duration and variability. Careful consideration of platelet hemostasis characteristics
and QT interval variability is recommended in the management of these patients.
Keywords:
chronic ischemic heart disease; COVID-19; QT interval dispersion; platelet hemostasis dysfunction; laser aggregometry
References
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China. 2019. N Engl J Med. 2020; 382(8): 727-33.
CrossRef
PubMed PubMedCentral
- Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020; 383(2): 120-8.
CrossRef
PubMed PubMedCentral
- Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017; 377(6): 562-72.
CrossRef
PubMed
- Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multi-organ response. Curr Probl Cardiol. 2020; 45(8): 100618.
CrossRef
PubMed PubMedCentral
- Kochi AN, Tagliari AP, Forleo GB, et al. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovascul Electrophysiol. 2020; 31(5): 1003-8.
CrossRef
PubMed PubMedCentral
- Schulman S, Hu Y, Konstantinides S. Venous thromboembolism in COVID-19. Thromb Haemostas. 2020; 120 (12): 1642-53.
CrossRef
PubMed PubMedCentral
- Katneni UK, Alexaki A, Hunt RC, Schiller T. coagulopathy and thrombosis as a result of severe COVID-19 infection: A microvascular focus. Thromb Haemostas. 2020; 120(12): 1668-79.
CrossRef
PubMed PubMedCentral
- Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I, Kritas S. Induction of pro-inflammatory cytokines (IL1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327-31.
- Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Chaolin Huang. Lancet 2020; 395: 497-506.
CrossRef
PubMed
- Tsuji H, Larson MG, Venditti FJJ, Manders ES, Evans JC, Feldman CL, Levy D. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996;94:2850-5.
CrossRef
PubMed
- Kleiger RE, Stein PK, Bigger JT. Heart rate variability: measurement and clinical utility. Ann Noninvasiv Electrocardiol. 2005;10(1): 88-101.
CrossRef
PubMed PubMedCentral
- Kaliyaperumal D, Rk K, Alagesan M, Ramalingam S. Characterization of cardiac autonomic function in COVID-19 using heart rate variability: A hospital based preliminary observational study. J Basic Clin Physiol Pharmacol. 2021;32(3): 247-53.
CrossRef
PubMed
- Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194: 927-9.
CrossRef
PubMed
- Wang Y, Andrews M, Yang Y, Lang S, Jin JW, CameronVendrig A, et al. Platelets in thrombosis and hemostasis: old topic with new mechanisms. Cardiovascul Hematol Dis Drug Targ. 2012;12(2):126-32.
CrossRef
PubMed
- Yougbaré I, Lang S, Yang H, Chen P, Zhao X, Tai WS, et al. Maternal antiplatelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. J Clin Investigat. 2015;125(4):1545-56.
CrossRef
PubMed PubMedCentral
- Minguito-Carazo C, et al. QT interval monitoring with handheld heart rhythm ECG device in COVID-19 patients. Global Heart. 2021; 16(1).
CrossRef
PubMed PubMedCentral
- Roger Esmel-Vilomara, Paola Dolader, Anna SabatéRotes, Antoni Soriano-Arandes, Ferran Gran, Ferran Rosés-Noguer. QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs. An Pediatr (Engl Ed). 2022 Mar;96(3):213-20.
CrossRef
PubMed PubMedCentral
- Evangelos Oikonomou, Stamatios Lampsas, Panagiotis Theofilis, Nektarios Souvaliotis, George Aggelos Papamikroulis, Ourania Katsarou, Konstantinos Kalogeras, Panteleimon Pantelidis, Theodore G Papaioannou, Aikaterini Tsatsaragkou, Georgios Marinos, Gerasimos Siasos, Dimitris Tousoulis, Manolis Vavuranakis. Impaired left ventricular deformation and ventricular-arterial coupling in post-COVID-19: association with autonomic dysregulation. Heart Vessels. 2023; 38(3):381-93.
CrossRef
PubMed PubMedCentral
- Domenico Cozzolino, Ciro Romano, et al. Long-term prognosis among COVID-19 patients: The predictive role played by hyperinflammation and arrhythmic disorders in fatal outcome.. J Clin Med. 2023;12(17).
CrossRef
PubMed PubMedCentral
- Mathias Baumert, Alberto Porta, Marc A Vos, Marek Malik, Jean-Philippe Couderc, Pablo Laguna, Gianfranco Piccirillo, Godfrey L Smith, Larisa G Tereshchenko, Paul GA Volders. QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: Position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology Europace. 2016 Jun;18(6):925-44.
CrossRef
PubMed PubMedCentral
- Zhilin Qu, James N Weiss. Cardiac alternans: From bedside to bench and back. Circ Res. 2023 Jan;132:127-49.
CrossRef
PubMed PubMedCentral
- Joseph A Varney, Vinh S Dong, Tiffany Tsao, Mariam S Sabir, Amanda T Rivera, Suhaib Ghula, et al. COVID-19 and arrhythmia: An overview. J Cardiol. 2022; Apr. 79(4):468-75.
CrossRef
PubMed PubMedCentral
- Khalid Changal, David Paternite, Sean Mack, Spiro Veria, Rehana Bashir, Mitra Patel, Ronak Soni, Muhammad Ali, Tanveer Mir, Mujeeb Sheikh, P Kasi Ramanathan. Coronavirus disease 2019 (COVID-19) and QTc prolongation BMC. Cardiovascul Dis. 2021 Mar 30; 21(1):158.
CrossRef
PubMed PubMedCentral
|